Literature DB >> 6279105

Evidence for more than one type of post-junctional alpha-adrenoceptor.

J C McGrath.   

Abstract

The concept of two types of alpha-adrenoceptor, alpha 1 located on smooth muscle and mediating contraction and alpha 2 located on nerve terminals and mediating inhibition of transmitter release, has broken down. In vivo it has been shown that post-junctional receptors, with characteristics closely related to those of the alpha 2-adrenoceptors at nerve terminals, can mediate pressor responses and are, "post-junctional alpha 2-adrenoceptors". Several differences among agonists in vitro have superficial similarities to the in vivo alpha 1/alpha 2 system but do not correspond precisely and seem to point to a subdivision of post-junctional alpha 1-adrenoceptors. A preliminary hypothesis is: in vivo alpha 1 is rapid in onset, short-lived, utilises internal Ca2+, prefers alkalosis and responds to short-term stimuli such as short bursts of nerve impulses or bolus injections of catecholamines; alpha 2 is slower in onset, longer-lived, utilises external Ca2+, prefers acidosis and responds to more prolonged stimuli such as circulating catecholamines; in vitro these categories of response occur but antagonists fail to define an alpha 1/alpha 2 split, suggesting that some critical factor is missing in vitro. The implications of these trends in alpha-adrenoceptor classification are discussed in relation to current pharmacological and biochemical methods for receptor typing, to the possible physiological actions and roles of such receptors and to structure/activity relationships among agonists and antagonists.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279105     DOI: 10.1016/0006-2952(82)90147-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  113 in total

1.  Pharmacological analysis of the novel, selective alpha1-adrenoceptor antagonist, KMD-3213, and its suitability as a tritiated radioligand.

Authors:  S Murata; T Taniguchi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

2.  Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland.

Authors:  A D Michel; D N Loury; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

3.  Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice.

Authors:  Chihiro Hosoda; Akito Tanoue; Mari Shibano; Yoshio Tanaka; Masami Hiroyama; Taka-aki Koshimizu; Susanna Cotecchia; Tadaichi Kitamura; Gozoh Tsujimoto; Katsuo Koike
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

4.  Comparison of activity of alpha-adrenoceptor agonists and antagonists in dog and rabbit saphenous vein.

Authors:  V A Alabaster; R F Keir; C J Peters
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

5.  Pharmacokinetic and pharmacodynamic studies with two alpha-adrenoceptor antagonists, doxazosin and prazosin in the rabbit.

Authors:  C A Hamilton; J L Reid; J Vincent
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

6.  [3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species.

Authors:  C B Neylon; R J Summers
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

7.  External Ca-independent release of norepinephrine by sympathomimetics and its role in negative feedback modulation.

Authors:  E S Vizi; G T Somogyi; L G Harsing; I Zimanyi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  The influence of alpha 1-adrenergic blockade on the acute antihypertensive effect of nifedipine.

Authors:  H E Sluiter; F T Huysmans; T A Thien; R A Koene
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Characterization of two distinct alpha-adrenoceptor binding sites in smooth muscle cell membranes from rat and bovine aorta.

Authors:  J J Descombes; J C Stoclet
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-05       Impact factor: 3.000

Review 10.  Neuronal control of coronary blood flow.

Authors:  D Baumgart; G Heusch
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.